Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,475 Обс.
$71,475 Обс.
Dec 31, 2026
$71,475 Обс.
$71,475 Обс.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Ринок відкрито: Jan 19, 2026, 3:15 PM ET
Обсяг
$71,475Дата завершення
Dec 31, 2026Ринок відкрито
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Обсяг
$71,475Дата завершення
Dec 31, 2026Ринок відкрито
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання